Search by Drug Name or NDC

    NDC 62037-0727-01 Methylphenidate Hydrochloride 54 mg/1 Details

    Methylphenidate Hydrochloride 54 mg/1

    Methylphenidate Hydrochloride is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is METHYLPHENIDATE HYDROCHLORIDE.

    Product Information

    NDC 62037-0727
    Product ID 62037-727_059600af-abec-4e0a-a978-dfd77056a8c8
    Associated GPIs 61400020100480
    GCN Sequence Number 047318
    GCN Sequence Number Description methylphenidate HCl TAB ER 24 54 MG ORAL
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 12248
    HICL Sequence Number 001682
    HICL Sequence Number Description METHYLPHENIDATE HCL
    Brand/Generic Generic
    Proprietary Name Methylphenidate Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methylphenidate Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 54
    Active Ingredient Units mg/1
    Substance Name METHYLPHENIDATE HYDROCHLORIDE
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA076655
    Listing Certified Through 2024-12-31

    Package

    NDC 62037-0727-01 (62037072701)

    NDC Package Code 62037-727-01
    Billing NDC 62037072701
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-727-01)
    Marketing Start Date 2019-03-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.8971
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description METHYLPHENIDATE ER 54 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 85ef422d-af27-4126-9841-6892af1871d6 Details

    Revised: 3/2022